BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 28382202)

  • 1. Mitochondria-targeted metformins: anti-tumour and redox signalling mechanisms.
    Kalyanaraman B; Cheng G; Hardy M; Ouari O; Sikora A; Zielonka J; Dwinell M
    Interface Focus; 2017 Apr; 7(2):20160109. PubMed ID: 28382202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modified Metformin as a More Potent Anticancer Drug: Mitochondrial Inhibition, Redox Signaling, Antiproliferative Effects and Future EPR Studies.
    Kalyanaraman B; Cheng G; Hardy M; Ouari O; Sikora A; Zielonka J; Dwinell MB
    Cell Biochem Biophys; 2017 Dec; 75(3-4):311-317. PubMed ID: 28429253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondria-Targeted Analogues of Metformin Exhibit Enhanced Antiproliferative and Radiosensitizing Effects in Pancreatic Cancer Cells.
    Cheng G; Zielonka J; Ouari O; Lopez M; McAllister D; Boyle K; Barrios CS; Weber JJ; Johnson BD; Hardy M; Dwinell MB; Kalyanaraman B
    Cancer Res; 2016 Jul; 76(13):3904-15. PubMed ID: 27216187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EPR Investigations to Study the Impact of Mito-Metformin on the Mitochondrial Function of Prostate Cancer Cells.
    d'Hose D; Mathieu B; Mignion L; Hardy M; Ouari O; Jordan BF; Sonveaux P; Gallez B
    Molecules; 2022 Sep; 27(18):. PubMed ID: 36144606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic inhibition of tumor cell proliferation by metformin and mito-metformin in the presence of iron chelators.
    Cheng G; Zielonka J; Hardy M; Ouari O; Chitambar CR; Dwinell MB; Kalyanaraman B
    Oncotarget; 2019 May; 10(37):3518-3532. PubMed ID: 31191823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiproliferative effects of mitochondria-targeted cationic antioxidants and analogs: Role of mitochondrial bioenergetics and energy-sensing mechanism.
    Cheng G; Zielonka J; McAllister D; Hardy M; Ouari O; Joseph J; Dwinell MB; Kalyanaraman B
    Cancer Lett; 2015 Aug; 365(1):96-106. PubMed ID: 26004344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploiting the tumor immune microenvironment and immunometabolism using mitochondria-targeted drugs: Challenges and opportunities in racial disparity and cancer outcome research.
    Kalyanaraman B
    FASEB J; 2022 Apr; 36(4):e22226. PubMed ID: 35233843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondria-targeted esculetin alleviates mitochondrial dysfunction by AMPK-mediated nitric oxide and SIRT3 regulation in endothelial cells: potential implications in atherosclerosis.
    Karnewar S; Vasamsetti SB; Gopoju R; Kanugula AK; Ganji SK; Prabhakar S; Rangaraj N; Tupperwar N; Kumar JM; Kotamraju S
    Sci Rep; 2016 Apr; 6():24108. PubMed ID: 27063143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondria-targeted hydroxyurea inhibits OXPHOS and induces antiproliferative and immunomodulatory effects.
    Cheng G; Hardy M; Topchyan P; Zander R; Volberding P; Cui W; Kalyanaraman B
    iScience; 2021 Jun; 24(6):102673. PubMed ID: 34189437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidiabetic Biguanides Radiosensitize Hypoxic Colorectal Cancer Cells Through a Decrease in Oxygen Consumption.
    de Mey S; Jiang H; Corbet C; Wang H; Dufait I; Law K; Bastien E; Verovski V; Gevaert T; Feron O; De Ridder M
    Front Pharmacol; 2018; 9():1073. PubMed ID: 30337872
    [No Abstract]   [Full Text] [Related]  

  • 11. Metformin Suppresses Diabetes-Accelerated Atherosclerosis via the Inhibition of Drp1-Mediated Mitochondrial Fission.
    Wang Q; Zhang M; Torres G; Wu S; Ouyang C; Xie Z; Zou MH
    Diabetes; 2017 Jan; 66(1):193-205. PubMed ID: 27737949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin inhibits human breast cancer cell growth by promoting apoptosis via a ROS-independent pathway involving mitochondrial dysfunction: pivotal role of superoxide dismutase (SOD).
    Sharma P; Kumar S
    Cell Oncol (Dordr); 2018 Dec; 41(6):637-650. PubMed ID: 30088260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cation-selective transporters are critical to the AMPK-mediated antiproliferative effects of metformin in human breast cancer cells.
    Cai H; Zhang Y; Han TK; Everett RS; Thakker DR
    Int J Cancer; 2016 May; 138(9):2281-92. PubMed ID: 26669511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-tumour effect of metformin in canine mammary gland tumour cells.
    Saeki K; Watanabe M; Tsuboi M; Sugano S; Yoshitake R; Tanaka Y; Ong SM; Saito T; Matsumoto K; Fujita N; Nishimura R; Nakagawa T
    Vet J; 2015 Aug; 205(2):297-304. PubMed ID: 25981932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methyl succinate antagonises biguanide-induced AMPK-activation and death of pancreatic beta-cells through restoration of mitochondrial electron transfer.
    Hinke SA; Martens GA; Cai Y; Finsi J; Heimberg H; Pipeleers D; Van de Casteele M
    Br J Pharmacol; 2007 Apr; 150(8):1031-43. PubMed ID: 17339833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic inhibition of mitochondrial reactive oxygen species with mito-TEMPO reduces diabetic cardiomyopathy.
    Ni R; Cao T; Xiong S; Ma J; Fan GC; Lacefield JC; Lu Y; Le Tissier S; Peng T
    Free Radic Biol Med; 2016 Jan; 90():12-23. PubMed ID: 26577173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain.
    Owen MR; Doran E; Halestrap AP
    Biochem J; 2000 Jun; 348 Pt 3(Pt 3):607-14. PubMed ID: 10839993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MIF/CD74 axis is a target for novel therapies in colon carcinomatosis.
    Bozzi F; Mogavero A; Varinelli L; Belfiore A; Manenti G; Caccia C; Volpi CC; Beznoussenko GV; Milione M; Leoni V; Gloghini A; Mironov AA; Leo E; Pilotti S; Pierotti MA; Bongarzone I; Gariboldi M
    J Exp Clin Cancer Res; 2017 Jan; 36(1):16. PubMed ID: 28114961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin Mediates Protection against
    Kajiwara C; Kusaka Y; Kimura S; Yamaguchi T; Nanjo Y; Ishii Y; Udono H; Standiford TJ; Tateda K
    J Immunol; 2018 Jan; 200(2):623-631. PubMed ID: 29246951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin: From Diabetes to Cancer-Unveiling Molecular Mechanisms and Therapeutic Strategies.
    Amengual-Cladera E; Morla-Barcelo PM; MorĂ¡n-Costoya A; Sastre-Serra J; Pons DG; Valle A; Roca P; Nadal-Serrano M
    Biology (Basel); 2024 Apr; 13(5):. PubMed ID: 38785784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.